Andrew E Gelman

Title: Andrew E Gelman: Innovator in Immunology

Introduction

Andrew E Gelman is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of immunology, holding a total of 4 patents. His work focuses on developing innovative solutions that address critical health issues.

Latest Patents

Among his latest patents is the invention titled "Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof." This patent provides compositions and methods related to immunology, specifically chemokine binding proteins and their applications. Another significant patent is "Anti-neutrophil activity on innate immune response," which discloses compositions, medical devices, and methods aimed at ameliorating sterile injury. This invention includes compositions featuring N-Acetylcysteine and an aminoquinoline, as well as medical devices with specific coatings.

Career Highlights

Andrew has worked with prestigious institutions, including Washington University and Quark Pharmaceuticals, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

He has collaborated with notable colleagues, including Elena Feinstein and Svetlana Adamsky, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Andrew E Gelman is a distinguished inventor whose work in immunology has led to valuable patents and collaborations. His contributions continue to influence the field and improve health outcomes.